4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Scilex Holding Company (SCLX) operates in the Drug Manufacturers - General industry and is headquartered in Palo Alto, United States with about 34 employees. Its market capitalization is roughly $65 million. In the fiscal year ended 2025-12-31, SCLX reported $30M in revenue and ($359M) in net income.
Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain.
Interactive charts & full statements → Open the SCLX valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $30M | $57M | $47M | $38M | — |
| Gross Profit | $20M | $40M | $31M | $27M | — |
| Operating Income (EBIT) | ($272M) | ($93M) | ($105M) | ($51M) | — |
| Net Income | ($359M) | ($73M) | ($114M) | ($23M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $9M | $5M | $11M | $10M | $5M | — |
| Gross Profit | $4M | $2M | $7M | $7M | $4M | — |
| Operating Income (EBIT) | ($32M) | ($38M) | ($186M) | ($20M) | ($28M) | — |
| Net Income | ($43M) | ($33M) | ($257M) | ($42M) | ($26M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $365M | $93M | $101M | $86M | — |
| Total Liabilities | $577M | $286M | $274M | $50M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SCLX viewer.
About TickerBase · Data methodology & sources